Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, November 11 at 2:00 PM ET

Register Free →

This Pre-Solicitation opportunity was posted on July 4, 2017. The submission period has ended. Browse the details below for market research, or find similar active opportunities.

Notice of Intent to Issue a Sole Source Purchase Order for High Quality Genomic Nucleic Acid

Awarded
FDA-SOL-17-1183074Federal

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

Active Opportunities Like This One

General Info

Agency

N/A

Contract Value

$25,000

NAICS

541711 - Research and Development in Biotechnology

Place of Performance

Not specified

Set-Aside

NONE

Award Issued Date

Documents

0

No documents available

Documents will appear here when they are available.

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

PhaseAwarded
Posted

Presolicitation

Awarded

Contract was awarded

Submission Closed

Find active opportunities like this

Get full access to discover similar active contracts, track opportunities, and build proposals with AI assistance.

Organization & Contact Information

Show more
AgencyN/A
Contacts1 person available
OfficeN/A
Organization / Agency
N/A
Office AddressN/A
Contacts
Linda TroutmanContract Specialist

Full Description

Show more
Notice of Intent to Issue a Sole Source purchase order for High Quality Genomic Nucleic Acid The Food and Drug Administration (FDA) intends to issue a sole-source purchase order to Tetracore, Inc., located at 9901 Belward Campus Drive, Suite 300, Rockville, Maryland. The anticipated purchase order is for high quality genomic nucleic acid. The genomic nucleic acid will be used to generate full length genomic sequence, assembly and metadata that will be deposited onto the FDA Database for Reference Grade Microbial Sequences (ARGOS) data base and made publically available via National Center for Biotechnology Information (NCBI) and FDA web portal. The rapid development and dissemination of High Throughput Sequencing (HTS) technologies for in vitro diagnostic medical devices have made the HTS technologies a prime candidate for a medical device of public health importance. To realize the potential of HTS as diagnostic devices and to correctly assess its potential to promoting public health, sequence data quality measures, and solid scientific evidence are needed to foster the acceptance and widespread use of sequence-based diagnostic device technology. The availability of high quality sequence and metadata will improve access to cutting-edge, safe, and effective medical devices of public health importance. Award will be made in accordance with Federal Acquisition Regulation (FAR) Part 6.302-1, only one responsible source and no other supplies or services will satisfy the agency requirements using Simplified Acquisition Procedures per FAR Part 13.5. This notice of intent is not a request for competitive quotes. However, all responsible sources may submit a capability statement within seven (7) days after the publication of this synopsis, which will be considered by the agency. Responses received after seven (7) days or without the required information may not be considered. A determination by the Government not to compete as a result, of information received is solely within the discretion of the Government. Information received will be considered solely for determining whether to conduct a competitive procurement. For information concerning this acquisition, contact Linda Troutman, Contract Specialist at contact@example.gov

Earlier notices in this NAICS code

Posted before this notice, open and closed

Find Active Opportunities Like This

Get AI-powered intelligence on the opportunities still open

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS